Today, Jane Radecki and Roger Schoenfeld of Ithaka S+R released a very interesting and wide-ranging study of the Impact of COVID-19 on the Research Enterprise. I've reproduced the Executive Summary below. This report echos many themes that we heard at our recent Executive Roundtables on Research Restart and Research Continuity (see https://www.cni.org/go/research-continuity-sept-2020-update) and goes into issues around funding and federal grants in depth. The report can be read online or downloaded as a PDF at:

https://sr.ithaka.org/publications/the-impacts-of-covid-19-on-the-research-enterprise/

Ithaka will discuss aspects of this work at the Fall CNI member meeting

My thanks to Ithaka for helping us to better understand these developments.

Clifford Lynch
Director, CNI


---------------------
From the Ithaka report:


The COVID-19 pandemic and associated disruptions have had a major impact on the US academic research enterprise. This report provides a landscape review of what is known about these impacts, from March through mid-October 2020, with an aim of identifying gaps that should be addressed. Our focus is on externally funded research, and therefore we emphasize STEM fields almost exclusively. As a result, we also focus on the largest research universities, which conduct an outsized share of this research and which are themselves quite reliant on the intellectual activity and revenues associated with it.
Our key findings include:
∙ The federal government provided substantial flexibility to universities in utilizing research funding at the beginning of the pandemic. In addition, there is little reason to anticipate substantial budget reductions among most major research funders. As a result of these factors, while universities face substantial declines to some revenue sources and risks to most others, externally funded scientific research is likely to be relatively stable. That said, the ways in which the academic research enterprise is interwoven with, and in some cases cross-subsidized by, instructional activities pose some risk to research support. There are substantial unanswered questions about how negative impacts to the business models of research universities will affect scientific research.
∙ Many traditional research activities were largely suspended in the spring into summer, other than COVID-19-related and other essential research. With federal flexibilities ending, universities scrambled to put in place necessary protections to allow laboratories and other research groups to safely resume their activities. Many but not all research activities have successfully restarted, even if not all are at full capacity. In parallel, the COVID-19 emergency led to substantial innovation in research collaboration and scholarly communication. It also demonstrated the limits of collaboration and communication infrastructure and services in the face of widespread attention to scientific progress and its politicization. There are substantial unanswered questions about the resiliency of the research enterprise and the permanence of the many adaptations to collaboration and scholarly communication that we have seen.
∙ The human impacts of the disruptions are vast. These include limitations and impediments facing international students and disruptions to researchers that differ by gender, caregiver status, and career level. There are substantial unanswered questions about international talent flows, the development of early career researchers, and setbacks in achieving gender equity.
As we write, the research enterprise is coming back to life after an unplanned and unprecedented stoppage. Given the uncertain nature of how the pandemic will proceed and what societal, economic, and educational changes will result, we expect other impacts to develop over the coming months and years.